Skip to main content

Published locations for Neoadjuvant dabrafenib and trametinib improves event-free survival in resectable melanoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Neoadjuvant dabrafenib and trametinib improves event-free survival in resectable melanoma

User login

  • Reset your password
  • /content/neoadjuvant-dabrafenib-and-trametinib-improves-event-free-survival-resectable-melanoma
  • /edermatologynews/article/157305/melanoma/neoadjuvant-dabrafenib-and-trametinib-improves-event-free
  • /oncologypractice/article/157305/melanoma/neoadjuvant-dabrafenib-and-trametinib-improves-event-free
  • /hematology-oncology/article/157305/melanoma/neoadjuvant-dabrafenib-and-trametinib-improves-event
  • /dermatology/article/157305/melanoma/neoadjuvant-dabrafenib-and-trametinib-improves-event-free